N
Natalia Wasilewska
Researcher at Medical University of Białystok
Publications - 21
Citations - 161
Natalia Wasilewska is an academic researcher from Medical University of Białystok. The author has contributed to research in topics: Metabolic syndrome & Nonalcoholic fatty liver disease. The author has an hindex of 5, co-authored 12 publications receiving 81 citations.
Papers
More filters
Journal ArticleDOI
Increased serum concentration of ceramides in obese children with nonalcoholic fatty liver disease.
Natalia Wasilewska,Anna Bobrus-Chociej,Ewa Harasim-Symbor,Eugeniusz Tarasów,Małgorzata Wojtkowska,Adrian Chabowski,Dariusz Marek Lebensztejn +6 more
TL;DR: Elevated ceramide concentrations in obese patients together with their significant correlation with insulin resistance parameters suggest their association with molecular pathways involved in insulin signaling impairment known to be strongly linked to pathogenesis of non-alcoholic fatty liver disease.
Journal ArticleDOI
Metabolomic profiling in children with inflammatory bowel disease.
Aleksandra Filimoniuk,Urszula Daniluk,Paulina Samczuk,Natalia Wasilewska,Piotr Jakimiec,Magdalena Kucharska,Dariusz Marek Lebensztejn,Michal Ciborowski +7 more
TL;DR: The aim of this study was to collect the knowledge about metabolomics in paediatric patients with CD or UC based on the currently published literature to identify disease biomarkers.
Journal ArticleDOI
Blood lipid profile and BMI-Z-score in adolescents with hyperuricemia
TL;DR: The results of this study confirm higher prevalence of hyperuricemia in males when compared to females and a stronger association of HU with BMI-Z-score and lipid profile in male adolescents and multiple regression does not confirm the independent association of SUA with lipid profile.
Journal ArticleDOI
From Nonalcoholic Fatty Liver Disease (NAFLD) to Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)-New Terminology in Pediatric Patients as a Step in Good Scientific Direction?
TL;DR: In this article, a new term combining metabolic dysfunction-associated fatty liver disease (MAFLD) was proposed to diagnose NAFLD in children and adolescents, based on these findings, which may be useful to diagnose MAFLD.
Journal ArticleDOI
Can hepatokines be regarded as novel non-invasive serum biomarkers of intrahepatic lipid content in obese children?
Marta Flisiak-Jackiewicz,Anna Bobrus-Chociej,Natalia Wasilewska,Eugeniusz Tarasów,Małgorzata Wojtkowska,Dariusz Marek Lebensztejn +5 more
TL;DR: FGF-21 can be considered as a suitable biomarker in predicting TILC and fatty liver in obese children.